Opinion: The Significance of Clinical Trial Transparency During the COVID-19 Pandemic

Clinical Researcher—September 2020 (Volume 34, Issue 8) PEER REVIEWED Dr. Kumari Priyanka, BDS, PGDCR; Tejas Thomas, MSc, PGDCR   Clinical trials lay the foundation for biomedical research to generate robust evidence on the safety and effectiveness of proposed treatments and/or preventive interventions for eventual use in routine clinical care. Clinical trials directly engage volunteer participants […]

Risk-Based Monitoring of Clinical Trials: COVID-19 and Paving the Road to the Future

Clinical Researcher—September 2020 (Volume 34, Issue 8) SPECIAL FEATURE Sandra "SAM" Sather, MS, BSN, CCRC, CCRA, FACRP; Jennifer Lawyer, RN, BS   Clinical research professionals are accustomed to sponsors requiring onsite monitoring to ensure human subject protection, data integrity, and quality. During the COVID-19 pandemic, however, clinical research sites have reduced the number of staff […]

RACE for Children Act Aims to Improve Pediatric Cancer Care

Clinical Researcher—September 2020 (Volume 34, Issue 8) RECRUITMENT & RETENTION Lynne Georgopoulos, RN, MSHS, RAC; S. Y. Amy Cheung, PhD   Approximately 1.8 million new cases of cancer will be diagnosed in the U.S. in 2020.{1} Less than 1% of them will be diagnosed in pediatric patients.{2} Although pediatric cancer is rare, it is the […]

Innovations are Expanding the Possibilities for Addressing COVID-19

Clinical Researcher—September 2020 (Volume 34, Issue 8) SCIENCE & SOCIETY Al O. Pacino; Yonnie Otieno   International efforts to curb the spread of COVID-19 have been on the rise. As a result, a focus has been put on the need for the discovery of lifesaving treatments and prevention. Cooperation between governments, biotechnology companies, and the […]